Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Scaleway is a French cloud provider under Iliad Group with ~€150M estimated revenue. Focused on European data sovereignty and GPU cloud for AI. HQ: Paris. Founded 1999.
Scaleway is a French cloud computing provider and subsidiary of Iliad Group, the telecommunications and technology conglomerate founded by billionaire Xavier Niel. Originally launched as Online.net in 1999 and rebranded as Scaleway in 2015, the company has grown into one of Europe's leading independent cloud providers, positioning itself as the European alternative to US hyperscalers for GDPR-sensitive workloads.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.